APO Research
Talk to an analyst

APO RESEARCH · REPORT

C13 Stable Isotope Labeled Biomolecules

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global C13 Stable Isotope Labeled Biomolecules Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchC13 Stable Isotope Labeled Biomolecules Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal C13 Stable Isotope Labeled Biomolecules Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal C13 Stable Isotope Labeled Biomolecules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal C13 Stable Isotope Labeled Biomolecules Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal C13 Stable Isotope Labeled Biomolecules Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global C13 Stable Isotope Labeled Biomolecules market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for C13 Stable Isotope Labeled Biomolecules is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of C13 Stable Isotope Labeled Biomolecules include Cambridge Isotope Laboratories, Icon Isotopes, IsoLife BV, LGC Standards, Medical Isotopes, Omicron Biochemicals, Sigma-Aldrich, Toronto Research Chemicals and WITEGA Laboratorien, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for C13 Stable Isotope Labeled Biomolecules, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of C13 Stable Isotope Labeled Biomolecules, also provides the sales of main regions and countries. Of the upcoming market potential for C13 Stable Isotope Labeled Biomolecules, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the C13 Stable Isotope Labeled Biomolecules sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global C13 Stable Isotope Labeled Biomolecules market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for C13 Stable Isotope Labeled Biomolecules sales, projected growth trends, production technology, application and end-user industry.

C13 Stable Isotope Labeled Biomolecules Segment by Company

Cambridge Isotope Laboratories

Icon Isotopes

IsoLife BV

LGC Standards

Medical Isotopes

Omicron Biochemicals

Sigma-Aldrich

Toronto Research Chemicals

WITEGA Laboratorien

Thermo Fisher Scientific

C13 Stable Isotope Labeled Biomolecules Segment by Type

Medical C13 Stable Isotope Labeled Biomolecules

Others

C13 Stable Isotope Labeled Biomolecules Segment by Application

Medical

Scientific Research

Industrial

Others

C13 Stable Isotope Labeled Biomolecules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C13 Stable Isotope Labeled Biomolecules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of C13 Stable Isotope Labeled Biomolecules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C13 Stable Isotope Labeled Biomolecules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of C13 Stable Isotope Labeled Biomolecules in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of C13 Stable Isotope Labeled Biomolecules manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, C13 Stable Isotope Labeled Biomolecules sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Medical C13 Stable Isotope Labeled Biomolecules Major Manufacturers Table 3. Others Major Manufacturers Table 4. Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Major Manufacturers Table 6. Scientific Research Major Manufacturers Table 7. Industrial Major Manufacturers Table 8. Others Major Manufacturers Table 9. C13 Stable Isotope Labeled Biomolecules Industry Trends Table 10. C13 Stable Isotope Labeled Biomolecules Industry Drivers Table 11. C13 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges Table 12. C13 Stable Isotope Labeled Biomolecules Industry Restraints Table 13. Global C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global C13 Stable Isotope Labeled Biomolecules Revenue by Region (2021-2026) & (US$ Million) Table 15. Global C13 Stable Isotope Labeled Biomolecules Revenue by Region (2027-2032) & (US$ Million) Table 16. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2021-2026) Table 17. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2027-2032) Table 18. Global C13 Stable Isotope Labeled Biomolecules Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 19. Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2021-2026) & (k tons) Table 20. Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2027-2032) & (k tons) Table 21. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2021-2026) Table 22. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2027-2032) Table 23. Global C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Manufacturers (2021-2026) Table 25. Global C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturers (2021-2026) Table 27. Global C13 Stable Isotope Labeled Biomolecules Sales Price (US$/ton) of Manufacturers (2021-2026) Table 28. Global C13 Stable Isotope Labeled Biomolecules Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global C13 Stable Isotope Labeled Biomolecules Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global C13 Stable Isotope Labeled Biomolecules Manufacturers, Product Type & Application Table 31. Global C13 Stable Isotope Labeled Biomolecules Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global C13 Stable Isotope Labeled Biomolecules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2026) & (US$ Million) Table 36. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2027-2032) & (US$ Million) Table 37. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2026) Table 38. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2027-2032) Table 39. Global C13 Stable Isotope Labeled Biomolecules Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 40. Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2026) & (k tons) Table 41. Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2027-2032) & (k tons) Table 42. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2026) Table 43. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2027-2032) Table 44. Global C13 Stable Isotope Labeled Biomolecules Price by Type (2021-2026) & (US$/ton) Table 45. Global C13 Stable Isotope Labeled Biomolecules Price by Type (2027-2032) & (US$/ton) Table 46. Global C13 Stable Isotope Labeled Biomolecules Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2026) & (US$ Million) Table 48. Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2027-2032) & (US$ Million) Table 49. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2026) Table 50. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2027-2032) Table 51. Global C13 Stable Isotope Labeled Biomolecules Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 52. Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2026) & (k tons) Table 53. Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2027-2032) & (k tons) Table 54. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2026) Table 55. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2027-2032) Table 56. Global C13 Stable Isotope Labeled Biomolecules Price by Application (2021-2026) & (US$/ton) Table 57. Global C13 Stable Isotope Labeled Biomolecules Price by Application (2027-2032) & (US$/ton) Table 58. Cambridge Isotope Laboratories Company Information Table 59. Cambridge Isotope Laboratories Business Overview Table 60. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 61. Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 62. Cambridge Isotope Laboratories Recent Development Table 63. Icon Isotopes Company Information Table 64. Icon Isotopes Business Overview Table 65. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 66. Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 67. Icon Isotopes Recent Development Table 68. IsoLife BV Company Information Table 69. IsoLife BV Business Overview Table 70. IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 71. IsoLife BV C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 72. IsoLife BV Recent Development Table 73. LGC Standards Company Information Table 74. LGC Standards Business Overview Table 75. LGC Standards C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. LGC Standards C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 77. LGC Standards Recent Development Table 78. Medical Isotopes Company Information Table 79. Medical Isotopes Business Overview Table 80. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 82. Medical Isotopes Recent Development Table 83. Omicron Biochemicals Company Information Table 84. Omicron Biochemicals Business Overview Table 85. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 87. Omicron Biochemicals Recent Development Table 88. Sigma-Aldrich Company Information Table 89. Sigma-Aldrich Business Overview Table 90. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 92. Sigma-Aldrich Recent Development Table 93. Toronto Research Chemicals Company Information Table 94. Toronto Research Chemicals Business Overview Table 95. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 97. Toronto Research Chemicals Recent Development Table 98. WITEGA Laboratorien Company Information Table 99. WITEGA Laboratorien Business Overview Table 100. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 102. WITEGA Laboratorien Recent Development Table 103. Thermo Fisher Scientific Company Information Table 104. Thermo Fisher Scientific Business Overview Table 105. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product Portfolio Table 107. Thermo Fisher Scientific Recent Development Table 108. North America C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2026) & (US$ Million) Table 109. North America C13 Stable Isotope Labeled Biomolecules Revenue by Type (2027-2032) & (US$ Million) Table 110. North America C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2026) & (k tons) Table 111. North America C13 Stable Isotope Labeled Biomolecules Sales by Type (2027-2032) & (k tons) Table 112. North America C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2021-2026) & (US$/ton) Table 113. North America C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2027-2032) & (US$/ton) Table 114. North America C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2026) & (US$ Million) Table 115. North America C13 Stable Isotope Labeled Biomolecules Revenue by Application (2027-2032) & (US$ Million) Table 116. North America C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2026) & (k tons) Table 117. North America C13 Stable Isotope Labeled Biomolecules Sales by Application (2027-2032) & (k tons) Table 118. North America C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2021-2026) & (US$/ton) Table 119. North America C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2027-2032) & (US$/ton) Table 120. North America C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. North America C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 122. North America C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 123. North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 124. North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (k tons) Table 125. North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (k tons) Table 126. North America C13 Stable Isotope Labeled Biomolecules Sales Price by Country (2021-2026) & (US$/ton) Table 127. North America C13 Stable Isotope Labeled Biomolecules Sales Price by Country (2027-2032) & (US$/ton) Table 128. United States C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 129. Canada C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 130. Mexico C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 131. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2026) & (US$ Million) Table 132. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Type (2027-2032) & (US$ Million) Table 133. Europe C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2026) & (k tons) Table 134. Europe C13 Stable Isotope Labeled Biomolecules Sales by Type (2027-2032) & (k tons) Table 135. Europe C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2021-2026) & (US$/ton) Table 136. Europe C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2027-2032) & (US$/ton) Table 137. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2026) & (US$ Million) Table 138. Europe C13 Stable Isotope Labeled Biomolecules Revenue by Application (2027-2032) & (US$ Million) Table 139. Europe C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2026) & (k tons) Table 140. Europe C13 Stable Isotope Labeled Biomolecules Sales by Application (2027-2032) & (k tons) Table 141. Europe C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2021-2026) & (US$/ton) Table 142. Europe C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2027-2032) & (US$/ton) Table 143. Europe C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Europe C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 145. Europe C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 146. Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 147. Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (k tons) Table 148. Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (k tons) Table 149. Europe C13 Stable Isotope Labeled Biomolecules Sales Price by Country (2021-2026) & (US$/ton) Table 150. Europe C13 Stable Isotope Labeled Biomolecules Sales Price by Country (2027-2032) & (US$/ton) Table 151. Germany C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 152. France C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 153. U.K. C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 154. Italy C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 155. Russia C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 156. Spain C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 157. Netherlands C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 158. Switzerland C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 159. Sweden C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 160. Poland C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 161. China C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2026) & (US$ Million) Table 162. China C13 Stable Isotope Labeled Biomolecules Revenue by Type (2027-2032) & (US$ Million) Table 163. China C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2026) & (k tons) Table 164. China C13 Stable Isotope Labeled Biomolecules Sales by Type (2027-2032) & (k tons) Table 165. China C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2021-2026) & (US$/ton) Table 166. China C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2027-2032) & (US$/ton) Table 167. China C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2026) & (US$ Million) Table 168. China C13 Stable Isotope Labeled Biomolecules Revenue by Application (2027-2032) & (US$ Million) Table 169. China C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2026) & (k tons) Table 170. China C13 Stable Isotope Labeled Biomolecules Sales by Application (2027-2032) & (k tons) Table 171. China C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2021-2026) & (US$/ton) Table 172. China C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2027-2032) & (US$/ton) Table 173. Asia C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2026) & (US$ Million) Table 174. Asia C13 Stable Isotope Labeled Biomolecules Revenue by Type (2027-2032) & (US$ Million) Table 175. Asia C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2026) & (k tons) Table 176. Asia C13 Stable Isotope Labeled Biomolecules Sales by Type (2027-2032) & (k tons) Table 177. Asia C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2021-2026) & (US$/ton) Table 178. Asia C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2027-2032) & (US$/ton) Table 179. Asia C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2026) & (US$ Million) Table 180. Asia C13 Stable Isotope Labeled Biomolecules Revenue by Application (2027-2032) & (US$ Million) Table 181. Asia C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2026) & (k tons) Table 182. Asia C13 Stable Isotope Labeled Biomolecules Sales by Application (2027-2032) & (k tons) Table 183. Asia C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2021-2026) & (US$/ton) Table 184. Asia C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2027-2032) & (US$/ton) Table 185. Asia C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 186. Asia C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 187. Asia C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 188. Asia C13 Stable Isotope Labeled Biomolecules Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 189. Asia C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (k tons) Table 190. Asia C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (k tons) Table 191. Asia C13 Stable Isotope Labeled Biomolecules Sales Price by Country (2021-2026) & (US$/ton) Table 192. Asia C13 Stable Isotope Labeled Biomolecules Sales Price by Country (2027-2032) & (US$/ton) Table 193. Japan C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 194. South Korea C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 195. India C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 196. Australia C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 197. Taiwan C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 198. Southeast Asia C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 199. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2026) & (US$ Million) Table 200. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue by Type (2027-2032) & (US$ Million) Table 201. SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2026) & (k tons) Table 202. SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Type (2027-2032) & (k tons) Table 203. SAMEA C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2021-2026) & (US$/ton) Table 204. SAMEA C13 Stable Isotope Labeled Biomolecules Sales Price by Type (2027-2032) & (US$/ton) Table 205. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2026) & (US$ Million) Table 206. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue by Application (2027-2032) & (US$ Million) Table 207. SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2026) & (k tons) Table 208. SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Application (2027-2032) & (k tons) Table 209. SAMEA C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2021-2026) & (US$/ton) Table 210. SAMEA C13 Stable Isotope Labeled Biomolecules Sales Price by Application (2027-2032) & (US$/ton) Table 211. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 212. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 213. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 214. SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 215. SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Country (2021-2026) & (k tons) Table 216. SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Country (2027-2032) & (k tons) Table 217. SAMEA C13 Stable Isotope Labeled Biomolecules Sales Price by Country (2021-2026) & (US$/ton) Table 218. SAMEA C13 Stable Isotope Labeled Biomolecules Sales Price by Country (2027-2032) & (US$/ton) Table 219. Brazil C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 220. Argentina C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 221. Chile C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 222. Colombia C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 223. Peru C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 224. Saudi Arabia C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 225. Israel C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 226. UAE C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 227. Turkey C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 228. Iran C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 229. Egypt C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Table 230. Key Raw Materials Table 231. Raw Materials Key Suppliers Table 232. C13 Stable Isotope Labeled Biomolecules Distributors List Table 233. C13 Stable Isotope Labeled Biomolecules Customers List Table 234. Research Programs/Design for This Report Table 235. Authors List of This Report Table 236. Secondary Sources Table 237. Primary Sources List of Figures Figure 1. C13 Stable Isotope Labeled Biomolecules Image Figure 2. Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global C13 Stable Isotope Labeled Biomolecules Market Size Share 2021 VS 2025 VS 2032 Figure 4. Medical C13 Stable Isotope Labeled Biomolecules Image Figure 5. Others Image Figure 6. Global C13 Stable Isotope Labeled Biomolecules Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global C13 Stable Isotope Labeled Biomolecules Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Image Figure 9. Scientific Research Image Figure 10. Industrial Image Figure 11. Others Image Figure 12. Global C13 Stable Isotope Labeled Biomolecules Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global C13 Stable Isotope Labeled Biomolecules Revenue (2021-2032) & (US$ Million) Figure 14. Global C13 Stable Isotope Labeled Biomolecules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2021-2032) Figure 17. Global C13 Stable Isotope Labeled Biomolecules Sales (2021-2032) & (k tons) Figure 18. Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 19. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico C13 Stable Isotope Labeled Biomolecules Sales YoY (2021-2032) & (k tons) Figure 21. Europe C13 Stable Isotope Labeled Biomolecules Sales YoY (2021-2032) & (k tons) Figure 22. China C13 Stable Isotope Labeled Biomolecules Sales YoY (2021-2032) & (k tons) Figure 23. Asia (Excluding China) C13 Stable Isotope Labeled Biomolecules Sales YoY (2021-2032) & (k tons) Figure 24. South America, Middle East and Africa C13 Stable Isotope Labeled Biomolecules Sales YoY (2021-2032) & (k tons) Figure 25. Global C13 Stable Isotope Labeled Biomolecules Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global C13 Stable Isotope Labeled Biomolecules Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2032) Figure 31. Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 32. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2032) Figure 34. Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2032) Figure 37. Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 38. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2032) Figure 40. North America C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2021-2032) Figure 41. North America C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2021-2032) Figure 42. North America C13 Stable Isotope Labeled Biomolecules Revenue Share by Application (2021-2032) Figure 43. North America C13 Stable Isotope Labeled Biomolecules Sales Share by Application (2021-2032) Figure 44. North America C13 Stable Isotope Labeled Biomolecules Revenue Share by Country (2021-2032) Figure 45. North America C13 Stable Isotope Labeled Biomolecules Sales Share by Country (2021-2032) Figure 46. Europe C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2021-2032) Figure 47. Europe C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2021-2032) Figure 48. Europe C13 Stable Isotope Labeled Biomolecules Revenue Share by Application (2021-2032) Figure 49. Europe C13 Stable Isotope Labeled Biomolecules Sales Share by Application (2021-2032) Figure 50. Europe C13 Stable Isotope Labeled Biomolecules Revenue Share by Country (2021-2032) Figure 51. Europe C13 Stable Isotope Labeled Biomolecules Sales Share by Country (2021-2032) Figure 52. China C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2021-2032) Figure 53. China C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2021-2032) Figure 54. China C13 Stable Isotope Labeled Biomolecules Revenue Share by Application (2021-2032) Figure 55. China C13 Stable Isotope Labeled Biomolecules Sales Share by Application (2021-2032) Figure 56. Asia C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2021-2032) Figure 57. Asia C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2021-2032) Figure 58. Asia C13 Stable Isotope Labeled Biomolecules Revenue Share by Application (2021-2032) Figure 59. Asia C13 Stable Isotope Labeled Biomolecules Sales Share by Application (2021-2032) Figure 60. Asia C13 Stable Isotope Labeled Biomolecules Revenue Share by Country (2021-2032) Figure 61. Asia C13 Stable Isotope Labeled Biomolecules Sales Share by Country (2021-2032) Figure 62. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue Share by Type (2021-2032) Figure 63. SAMEA C13 Stable Isotope Labeled Biomolecules Sales Share by Type (2021-2032) Figure 64. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue Share by Application (2021-2032) Figure 65. SAMEA C13 Stable Isotope Labeled Biomolecules Sales Share by Application (2021-2032) Figure 66. SAMEA C13 Stable Isotope Labeled Biomolecules Revenue Share by Country (2021-2032) Figure 67. SAMEA C13 Stable Isotope Labeled Biomolecules Sales Share by Country (2021-2032) Figure 68. C13 Stable Isotope Labeled Biomolecules Value Chain Figure 69. Manufacturing Cost Structure Figure 70. C13 Stable Isotope Labeled Biomolecules Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Medical C13 Stable Isotope Labeled Biomolecules
  • Others
Applications
  • Medical
  • Scientific Research
  • Industrial
  • Others
Companies covered
  • Cambridge Isotope Laboratories
  • Icon Isotopes
  • IsoLife BV
  • LGC Standards
  • Medical Isotopes
  • Omicron Biochemicals
  • Sigma-Aldrich
  • Toronto Research Chemicals
  • WITEGA Laboratorien
  • Thermo Fisher Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 C13 Stable Isotope Labeled Biomolecules Market by Type
  3. 1.2.1 Global C13 Stable Isotope Labeled Biomolecules Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Medical C13 Stable Isotope Labeled Biomolecules
  5. 1.2.3 Others
  6. 1.3 C13 Stable Isotope Labeled Biomolecules Market by Application
  7. 1.3.1 Global C13 Stable Isotope Labeled Biomolecules Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical
  9. 1.3.3 Scientific Research
  10. 1.3.4 Industrial
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 C13 Stable Isotope Labeled Biomolecules Market Dynamics
  1. 2.1 C13 Stable Isotope Labeled Biomolecules Industry Trends
  2. 2.2 C13 Stable Isotope Labeled Biomolecules Industry Drivers
  3. 2.3 C13 Stable Isotope Labeled Biomolecules Industry Opportunities and Challenges
  4. 2.4 C13 Stable Isotope Labeled Biomolecules Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global C13 Stable Isotope Labeled Biomolecules Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region
  3. 3.2.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region (2021-2026)
  5. 3.2.3 Global C13 Stable Isotope Labeled Biomolecules Revenue by Region (2027-2032)
  6. 3.2.4 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Region (2021-2032)
  7. 3.3 Global C13 Stable Isotope Labeled Biomolecules Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global C13 Stable Isotope Labeled Biomolecules Sales by Region
  9. 3.4.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2021-2026)
  11. 3.4.3 Global C13 Stable Isotope Labeled Biomolecules Sales by Region (2027-2032)
  12. 3.4.4 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers
  2. 4.1.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global C13 Stable Isotope Labeled Biomolecules Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers
  6. 4.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global C13 Stable Isotope Labeled Biomolecules Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global C13 Stable Isotope Labeled Biomolecules Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global C13 Stable Isotope Labeled Biomolecules Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global C13 Stable Isotope Labeled Biomolecules Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global C13 Stable Isotope Labeled Biomolecules Manufacturers, Product Type & Application
  13. 4.7 Global C13 Stable Isotope Labeled Biomolecules Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global C13 Stable Isotope Labeled Biomolecules Market CR5 and HHI
  16. 4.8.2 2025 C13 Stable Isotope Labeled Biomolecules Tier 1, Tier 2, and Tier 3
5 C13 Stable Isotope Labeled Biomolecules Market by Type
  1. 5.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type
  2. 5.1.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Type (2021-2032)
  5. 5.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Type
  6. 5.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Type (2021-2032)
  9. 5.3 Global C13 Stable Isotope Labeled Biomolecules Price by Type
6 C13 Stable Isotope Labeled Biomolecules Market by Application
  1. 6.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application
  2. 6.1.1 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global C13 Stable Isotope Labeled Biomolecules Revenue Market Share by Application (2021-2032)
  5. 6.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Application
  6. 6.2.1 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global C13 Stable Isotope Labeled Biomolecules Sales Market Share by Application (2021-2032)
  9. 6.3 Global C13 Stable Isotope Labeled Biomolecules Price by Application
7 Company Profiles
  1. 7.1 Cambridge Isotope Laboratories
  2. 7.1.1 Cambridge Isotope Laboratories Company Information
  3. 7.1.2 Cambridge Isotope Laboratories Business Overview
  4. 7.1.3 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Cambridge Isotope Laboratories C13 Stable Isotope Labeled Biomolecules Product Portfolio
  6. 7.1.5 Cambridge Isotope Laboratories Recent Developments
  7. 7.2 Icon Isotopes
  8. 7.2.1 Icon Isotopes Company Information
  9. 7.2.2 Icon Isotopes Business Overview
  10. 7.2.3 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Icon Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
  12. 7.2.5 Icon Isotopes Recent Developments
  13. 7.3 IsoLife BV
  14. 7.3.1 IsoLife BV Company Information
  15. 7.3.2 IsoLife BV Business Overview
  16. 7.3.3 IsoLife BV C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 IsoLife BV C13 Stable Isotope Labeled Biomolecules Product Portfolio
  18. 7.3.5 IsoLife BV Recent Developments
  19. 7.4 LGC Standards
  20. 7.4.1 LGC Standards Company Information
  21. 7.4.2 LGC Standards Business Overview
  22. 7.4.3 LGC Standards C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 LGC Standards C13 Stable Isotope Labeled Biomolecules Product Portfolio
  24. 7.4.5 LGC Standards Recent Developments
  25. 7.5 Medical Isotopes
  26. 7.5.1 Medical Isotopes Company Information
  27. 7.5.2 Medical Isotopes Business Overview
  28. 7.5.3 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Medical Isotopes C13 Stable Isotope Labeled Biomolecules Product Portfolio
  30. 7.5.5 Medical Isotopes Recent Developments
  31. 7.6 Omicron Biochemicals
  32. 7.6.1 Omicron Biochemicals Company Information
  33. 7.6.2 Omicron Biochemicals Business Overview
  34. 7.6.3 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Omicron Biochemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
  36. 7.6.5 Omicron Biochemicals Recent Developments
  37. 7.7 Sigma-Aldrich
  38. 7.7.1 Sigma-Aldrich Company Information
  39. 7.7.2 Sigma-Aldrich Business Overview
  40. 7.7.3 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sigma-Aldrich C13 Stable Isotope Labeled Biomolecules Product Portfolio
  42. 7.7.5 Sigma-Aldrich Recent Developments
  43. 7.8 Toronto Research Chemicals
  44. 7.8.1 Toronto Research Chemicals Company Information
  45. 7.8.2 Toronto Research Chemicals Business Overview
  46. 7.8.3 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Toronto Research Chemicals C13 Stable Isotope Labeled Biomolecules Product Portfolio
  48. 7.8.5 Toronto Research Chemicals Recent Developments
  49. 7.9 WITEGA Laboratorien
  50. 7.9.1 WITEGA Laboratorien Company Information
  51. 7.9.2 WITEGA Laboratorien Business Overview
  52. 7.9.3 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 WITEGA Laboratorien C13 Stable Isotope Labeled Biomolecules Product Portfolio
  54. 7.9.5 WITEGA Laboratorien Recent Developments
  55. 7.10 Thermo Fisher Scientific
  56. 7.10.1 Thermo Fisher Scientific Company Information
  57. 7.10.2 Thermo Fisher Scientific Business Overview
  58. 7.10.3 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Thermo Fisher Scientific C13 Stable Isotope Labeled Biomolecules Product Portfolio
  60. 7.10.5 Thermo Fisher Scientific Recent Developments
8 North America
  1. 8.1 North America C13 Stable Isotope Labeled Biomolecules Market Size by Type
  2. 8.1.1 North America C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032)
  3. 8.1.2 North America C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032)
  4. 8.1.3 North America C13 Stable Isotope Labeled Biomolecules Price by Type (2021-2032)
  5. 8.2 North America C13 Stable Isotope Labeled Biomolecules Market Size by Application
  6. 8.2.1 North America C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032)
  7. 8.2.2 North America C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032)
  8. 8.2.3 North America C13 Stable Isotope Labeled Biomolecules Price by Application (2021-2032)
  9. 8.3 North America C13 Stable Isotope Labeled Biomolecules Market Size by Country
  10. 8.3.1 North America C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America C13 Stable Isotope Labeled Biomolecules Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America C13 Stable Isotope Labeled Biomolecules Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe C13 Stable Isotope Labeled Biomolecules Market Size by Type
  2. 9.1.1 Europe C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032)
  3. 9.1.2 Europe C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032)
  4. 9.1.3 Europe C13 Stable Isotope Labeled Biomolecules Price by Type (2021-2032)
  5. 9.2 Europe C13 Stable Isotope Labeled Biomolecules Market Size by Application
  6. 9.2.1 Europe C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032)
  7. 9.2.2 Europe C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032)
  8. 9.2.3 Europe C13 Stable Isotope Labeled Biomolecules Price by Application (2021-2032)
  9. 9.3 Europe C13 Stable Isotope Labeled Biomolecules Market Size by Country
  10. 9.3.1 Europe C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe C13 Stable Isotope Labeled Biomolecules Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe C13 Stable Isotope Labeled Biomolecules Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China C13 Stable Isotope Labeled Biomolecules Market Size by Type
  2. 10.1.1 China C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032)
  3. 10.1.2 China C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032)
  4. 10.1.3 China C13 Stable Isotope Labeled Biomolecules Price by Type (2021-2032)
  5. 10.2 China C13 Stable Isotope Labeled Biomolecules Market Size by Application
  6. 10.2.1 China C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032)
  7. 10.2.2 China C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032)
  8. 10.2.3 China C13 Stable Isotope Labeled Biomolecules Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia C13 Stable Isotope Labeled Biomolecules Market Size by Type
  2. 11.1.1 Asia C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032)
  3. 11.1.2 Asia C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032)
  4. 11.1.3 Asia C13 Stable Isotope Labeled Biomolecules Price by Type (2021-2032)
  5. 11.2 Asia C13 Stable Isotope Labeled Biomolecules Market Size by Application
  6. 11.2.1 Asia C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032)
  7. 11.2.2 Asia C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032)
  8. 11.2.3 Asia C13 Stable Isotope Labeled Biomolecules Price by Application (2021-2032)
  9. 11.3 Asia C13 Stable Isotope Labeled Biomolecules Market Size by Country
  10. 11.3.1 Asia C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia C13 Stable Isotope Labeled Biomolecules Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia C13 Stable Isotope Labeled Biomolecules Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA C13 Stable Isotope Labeled Biomolecules Market Size by Type
  2. 12.1.1 SAMEA C13 Stable Isotope Labeled Biomolecules Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Type (2021-2032)
  4. 12.1.3 SAMEA C13 Stable Isotope Labeled Biomolecules Price by Type (2021-2032)
  5. 12.2 SAMEA C13 Stable Isotope Labeled Biomolecules Market Size by Application
  6. 12.2.1 SAMEA C13 Stable Isotope Labeled Biomolecules Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Application (2021-2032)
  8. 12.2.3 SAMEA C13 Stable Isotope Labeled Biomolecules Price by Application (2021-2032)
  9. 12.3 SAMEA C13 Stable Isotope Labeled Biomolecules Market Size by Country
  10. 12.3.1 SAMEA C13 Stable Isotope Labeled Biomolecules Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA C13 Stable Isotope Labeled Biomolecules Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA C13 Stable Isotope Labeled Biomolecules Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 C13 Stable Isotope Labeled Biomolecules Value Chain Analysis
  2. 13.1.1 C13 Stable Isotope Labeled Biomolecules Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 C13 Stable Isotope Labeled Biomolecules Production Mode & Process
  6. 13.2 C13 Stable Isotope Labeled Biomolecules Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 C13 Stable Isotope Labeled Biomolecules Distributors
  9. 13.2.3 C13 Stable Isotope Labeled Biomolecules Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst